Article Details
Retrieved on: 2022-11-05 13:59:16
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
NGM Biopharmaceuticals ( NASDAQ:NGM ) Third Quarter 2022 Results Key Financial Results Revenue: US$7.91m (down 57% from...
Article found on: simplywall.st
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here